Isonipecotic Acidum CAS 498-94-2

Description:

Nomen chemicum: Isonipecoticum acidum

CAS: 498-94-2

Aspectus: Crystallinus Powder Alba

Intenta: 98.0%~ 102.0%

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Acidum isonipecoticum
Synonyma 4-Piperidine carboxylic Acidum;H-DL-Inp-OH
CAS Number 498-94-2
CATTUS Number RF-PI285
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C6H11NO2
M. Pondus 129.16
Solubilitas Solubilitas in aqua: Ipsum sedat Turbidity
Shipping Condition Uit sub Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Crystallina pulveris alba
Liquescens punctum 300℃ min
Lepidium sativum IR, NMR
Assay 98.0%~ 102.0%
Damnum in Siccatio ≤1.0%
Residere in Ignition ≤1.0%
Bacterial Emdotoxins ≤5IU/mg
Test Standard Enterprise Latin;Pharmacopoeia Sinica (CP)
Consuetudinem Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

1

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica et supplementum acidi isonipecotici, 4-piperidinecarboxylici acidi (CAS: 498-94-2) cum qualitate, late in synthesi organica adhibita, synthesis intermediorum pharmaceuticae et pharmaceuticae Ingredientis activae (. API) synthesis.

Acidum isonipecoticum, 4-Piperidinecarboxylicum acidum (CAS: 498-94-2) magni ponderis est ad synthesim alkyl piperidini et acidorum piperazini hydroxamici sicut inhibitores HDAC.Usus est etiam in synthesi derivatorum antibioticorum nitroxolini pro cathepsin B inhibitionis.

Applicationem
Reactant ad summam;
Derivationes nitroxolineae antibioticae pro cathepsin inhibitionis B
sphingosine-1-phosphate receptor agonistae
RhoA inhibitores morborum cardiovasculares illic
Alkyl piperidine et acida hydroxamic sicut HDAC inhibitores
CHK1 inhibitors
IKK2 inhibitores investigationum in arthritis rheumatoideis curationes

Epistulam tuam hic scribe et mitte nobis